Colorectal cancer with synchronous distant metastases: rationale for cytoreductive surgery and its perspectives – a surgeons view

Colorectal cancer with synchronous distant metastases: rationale for cytoreductive surgery and its perspectives – a surgeons view

A rationale for cytoreductive surgery in colorectal cancer patients with multiple liver metastases is discussed in the article. Not only does it improve their quality of life and prevent life-threatening complications, but also facilitates further systemic treatment. Symptomatic surgery (colostomies...

Full description

Bibliographic Details
Main Authors:	V. A. Aliyev, Yu. A. Barsukov, A. V. Nikolayev, R. I. Tamrazov, Z. Z. Mamedli, A. O. Atroshchenko, D. V. Kuzmichev
Format:	Article
Language:	Russian
Published:	“ABV-press” Publishing house”, LLC 2015-02-01
Series:	Тазовая хирургия и онкология
Subjects:	metastatic colorectal cancer rectal cancer cytoreductive surgery chemotherapy neoadjuvant treatment r0 resection
Online Access:	https://ok.abvpress.ru/jour/article/view/60

Similar Items

CURRENT TREATMENT POLICY FOR RECTAL CANCER WITH SYNCHRONOUS DISTANT METASTASES (A CLINICAL CASE)
by: M. I. Davydov, et al.
Published: (2015-02-01)

Metastatic colorectal cancer. Evolution of treatment strategies: surgeons’ point of view
by: V. A. Aliev, et al.
Published: (2021-06-01)

Clinical Utility of Preoperative Assessment in Ovarian Cancer Cytoreduction
by: Pratistha Koirala, et al.
Published: (2020-08-01)

Health-Related Quality of Life following Cytoreductive Radical Prostatectomy in Patients with De-Novo Oligometastatic Prostate Cancer
by: Michael Chaloupka, et al.
Published: (2021-11-01)

Neoadjuvant chemotherapy in the treatment of rectal cancer without mesorectal fascia involvement but with negative prognostic factors
by: S. O. Kochkina, et al.
Published: (2020-08-01)

Neoadjuvant chemotherapy does not improve survival for patients with high volume colorectal peritoneal metastases undergoing cytoreductive surgery
by: Mina Sarofim, et al.
Published: (2024-04-01)

Multimodality treatment in patients with operable distal rectal cancer
by: Yu. A. Barsukov, et al.
Published: (2015-02-01)

History of laparoscopic surgery
by: I. E. Chatkov, et al.
Published: (2015-02-01)

Neoadjuvant chemotherapy is associated with a high rate of perioperative blood transfusion at the time of interval cytoreductive surgery
by: Kevin W McCool, et al.
Published: (2018-10-01)

The role of cytoreduction surgery in advanced ovarian cancer (review)
by: R K Tandelov, et al.
Published: (2018-03-01)

Quaternary and beyond cytoreduction: An updated and expanded analysis
by: Beryl L. Manning-Geist, et al.
Published: (2021-08-01)

An Updated Systematic and Comprehensive Review of Cytoreductive Prostatectomy for Metastatic Prostate Cancer
by: Takafumi Yanagisawa, et al.
Published: (2023-02-01)

Survival impact of bowel resection at the time of interval cytoreductive surgery for advanced ovarian cancer
by: Blair McNamara, et al.
Published: (2021-11-01)

Impact of prehabilitation during neoadjuvant chemotherapy and interval cytoreductive surgery on ovarian cancer patients: a pilot study
by: Ester Miralpeix, et al.
Published: (2022-02-01)

Cytoreductive radiotherapy combined with abiraterone in metastatic castration-resistance prostate cancer: a single center experience
by: Yang Liu, et al.
Published: (2021-01-01)

Comprehensive treatment of rectal cancer patients with synchronous distant metastases
by: V. A. Aliev, et al.
Published: (2018-12-01)

Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes
by: Daniele Marrelli, et al.
Published: (2022-12-01)

Risk of complications and urinary incontinence following cytoreductive prostatectomy: a multi-institutional study
by: Dae Keun Kim, et al.
Published: (2018-01-01)

The role of active surveillance and cytoreductive nephrectomy in metastatic renal cell carcinoma
by: Amanda Nizam, et al.
Published: (2020-01-01)

New Paradigms for Cytoreductive Nephrectomy
by: Benjamin J. Lichtbroun, et al.
Published: (2022-05-01)

Advanced distal rectal cancer: possibilities of sphincter-sparing surgeries in combination with neoadjuvant therapy
by: Yu. A. Barsukov, et al.
Published: (2020-08-01)

Comparison of Cytoreductive Surgery and Resection of Isolated Peritoneal Metastases in Patients with Peritoneal Metastases from Colorectal Cancer: A Retrospective Study
by: Shinya Yoshida, et al.
Published: (2023-04-01)

Do Metastatic Kidney Cancer Patients Benefit From Cytoreductive Nephrectomy? A Real-World Retrospective Study From the SEER Database
by: Cheng Li, et al.
Published: (2021-08-01)

Repeat cytoreductive surgery with HIPEC for colorectal peritoneal metastases: a systematic review
by: Mina Sarofim, et al.
Published: (2024-04-01)

Intensification of neoadjuvant therapy in patients with locally advanced rectal cancer
by: Z. Z. Mamedli, et al.
Published: (2021-11-01)

Long Term Survival after Cytoreductive Surgery Combined with Perioperative Chemotherapy in Gastric Cancer Patients with Peritoneal Metastasis
by: Yutaka Yonemura, et al.
Published: (2020-01-01)

A mouse model of neoadjuvant chemotherapy followed by interval cytoreductive surgery indicates impaired efficacy of perioperative cisplatin
by: Mitchell Clark, et al.
Published: (2021-11-01)

Survival for patients with metastatic colon cancer underwent cytoreductive colectomy in the era of rapid development of anticancer drugs: A real-world analysis based on updated population dataset of 2004–2018
by: Guangran Meng, et al.
Published: (2022-10-01)

Developing a Core Outcome Set for Cytoreductive Surgery for Colorectal Cancer with Peritoneal Metastases: A Mixed-Method Study Protocol
by: Pratik Raichurkar, et al.
Published: (2024-01-01)

Neoadjuvant chemotherapy in the combination treatment for locally advanced rectal cancer: currently available options
by: D. V. Kuzmichev, et al.
Published: (2018-11-01)

ORGAN SAVING TREATMENT OF RECTAL CANCER
by: A. O. Rasulov, et al.
Published: (2017-01-01)

Impact of tumor cytoreduction in metastatic prostate cancer
by: Sow Y, et al.
Published: (2019-05-01)

Comparative study of quality of life, adverse effects after cytoreduction and HIPEC in stage IIIA-IIIC ovarian cancer
by: A. I. Rybin, et al.
Published: (2018-10-01)

Comparative study of quality of life, adverse effects after cytoreduction and HIPEC in stage IIIA-IIIC ovarian cancer
by: A. I. Rybin, et al.
Published: (2018-10-01)

Outcomes of sphincter-sparing surgeries in patients with rectal cancer: long-term experience of a specialized clinic
by: R. I. Tamrazov, et al.
Published: (2019-06-01)

Relationship Between Neoadjuvant Chemotherapy and Log Odds of Positive Lymph Nodes and Their Prognostic Role in Advanced Ovarian Cancer Patients With Optimal Cytoreductive Surgery
by: Yue-min Hou, et al.
Published: (2022-05-01)

Neoadjuvant chemotherapy for advanced stage endometrial cancer: A systematic review
by: Allan B. Huang, et al.
Published: (2021-11-01)

Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?
by: Pravesh Dhiman, et al.
Published: (2022-07-01)

Is Optimal Cytoreduction Post Neoadjuvant Chemotherapy the Only Prognostic Factor in Advanced Ovarian Cancer?
by: Pravesh Dhiman, et al.
Published: (2022-07-01)

Cytoreductive surgery and hyperthermal intraperitoneal chemoperfusion in colorectal cancer and cancer of ovaries: our experience and perspectives of a new method
by: A. V. Malynovskyi, et al.
Published: (2020-10-01)